RadNet

Insmed

Wave Life Sciences

Intra-Cellular Therapies

Livanova

Blueprint Medicines

Merit Medical Systems

Soleno Therapeutics

Collegium Pharmaceutical

NeoGenomics

F/m Emerald Life Sciences Innovation ETF

LFSC is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities.

LANCASTER, Pa.--(BUSINESS WIRE)--Emerald Advisers, in partnership with F/m Investments, today announces the launch of the F/m Emerald Life Sciences Innovation ETF (LFSC), now trading on the Nasdaq Stock Market under the ticker LFSC. This ETF offers investors exposure to the most innovative companies in the life sciences sector, focusing on biotech, healthcare, and medical device advancements. “We are excited to bring this ETF to market, offering investors access to some of the most cutting-edge.

Emerald Advisers and F/m Investments Announce the Launch of the F/m Emerald Life Sciences Innovation ETF (LFSC)

News for F/m Emerald Life Sciences Innovation ETF ETF (LFSC)